HLA-DRB1 was previously reported by GWAS to be associated with asthma (19), rheumatoid arthritis (20) and systemic lupus erythematosus (21), implying its potential role in immune system modulation and it could thus be a candidate modifier of the disease. Here, HLA-DRB1 is linked to systemic lupus erythematosus.